in series 1 experiments , it was unaltered by vehicle ( +0.3 +/- 0.9 mmhg , n = 9 , ns ) , was reduced by an ang ii antagonist , saralasin ( -2.4 +/- 1.1 mmhg , n = 8 , p less than 0.0005 ) , and by a txa2 antagonist sq 29,548 ( -4.8 +/- 0.6 mmhg , n = 11 , p less than 0.0001 ) .
C0003009
ang ii
C0036193
saralasin